Cencora (WBO:ABC) Total Operating Expense: €7,063 Mil (TTM As of Mar. 2026)


WBO:ABC Cencora Inc WBO:ABC
69 GF Score
Price €254.30
GF Value €259.48
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Total Operating Expense?

Cencora WBO:ABC -0.27% 69 Total Operating Expense is €7,063 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.48 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's Total Operating Expense for the three months ended in Mar. 2026 was €1,926 Mil. Cencora's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €7,063 Mil.

Cencora Total Operating Expense Related Terms

Cencora Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Cencora's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Total Operating Expense Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,484.51 5,598.29 5,878.63 6,084.53 6,428.27

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,720.37 1,670.60 1,710.51 1,755.56 1,926.23
WBO:ABC
69GF Score
Cencora Inc WBO:ABC
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €7,063 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €7,063 Mil mean?
Cencora (WBO:ABC) has a Total Operating Expense of €7,063 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Cencora and its competitors.
Is Cencora's Total Operating Expense too high?
Cencora's current Total Operating Expense is €7,063 Mil. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Total Operating Expense compare to CAH and MCK?
Cencora's Total Operating Expense of €7,063 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Distribution company?
A good Total Operating Expense depends on the Medical Distribution industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Cencora and its competitors. Cencora's current Total Operating Expense is €7,063 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.48, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current Total Operating Expense is €7,063 Mil. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Total Operating Expense is €7,063 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be undervalued. The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.48. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Total Operating Expense: €7,063 Mil
  • GF Value™: €259.48 vs. price of €254.30 (2% below fair value)
  • GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score

Get the complete analysis for WBO:ABC

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€254.30
Price
€259.48
GF Value